Neurocrine Biosciences, Inc. (NBIX)
NASDAQ: NBIX · Real-Time Price · USD
116.87
-3.56 (-2.96%)
At close: May 13, 2025, 4:00 PM
117.47
+0.60 (0.51%)
Pre-market: May 14, 2025, 6:08 AM EDT

Neurocrine Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
194.1233251.1262.9340.8187.1
Upgrade
Short-Term Investments
749.4843.1780.5726.4370.5613.9
Upgrade
Cash & Short-Term Investments
943.51,0761,032989.3711.3801
Upgrade
Cash Growth
-22.06%4.31%4.28%39.08%-11.20%19.46%
Upgrade
Receivables
516479.1439.3350185.5157.1
Upgrade
Inventory
59.157.438.335.130.528
Upgrade
Other Current Assets
119.3112.197.879.145.530.1
Upgrade
Total Current Assets
1,6381,7251,6071,454972.81,016
Upgrade
Property, Plant & Equipment
589.2592347.3145.6155.8127.4
Upgrade
Long-Term Investments
909.5864.3849.4401.5624.4265.3
Upgrade
Goodwill
-5.75.85.4--
Upgrade
Other Intangible Assets
36.436.535.537.2--
Upgrade
Long-Term Deferred Tax Assets
499.4485.7362.6305.9315.1319.4
Upgrade
Other Long-Term Assets
15.39.843.819.64.46.4
Upgrade
Total Assets
3,6883,7193,2512,3692,0731,735
Upgrade
Accounts Payable
110110133.367.351.539.4
Upgrade
Accrued Expenses
339.8351.6315.5271.3111.694.7
Upgrade
Current Portion of Long-Term Debt
--170.1169.4--
Upgrade
Current Portion of Leases
45.640.6----
Upgrade
Current Income Taxes Payable
25.4--9--
Upgrade
Current Unearned Revenue
----62.734.6
Upgrade
Other Current Liabilities
2.15.535.920.72017.8
Upgrade
Total Current Liabilities
522.9507.7654.8537.7245.8186.5
Upgrade
Long-Term Debt
----335.1317.9
Upgrade
Long-Term Leases
447.5455.1258.393.5105.394.4
Upgrade
Other Long-Term Liabilities
181.6166.2106.329.712.39.7
Upgrade
Total Liabilities
1,1521,1291,019660.9698.5608.5
Upgrade
Common Stock
0.10.10.10.10.10.1
Upgrade
Additional Paid-In Capital
2,5322,5552,3822,1222,0111,850
Upgrade
Retained Earnings
-5.329.2-157.1-406.8-635.8-725.4
Upgrade
Comprehensive Income & Other
95.87-7.9-1.71.8
Upgrade
Shareholders' Equity
2,5362,5902,2321,7081,3741,126
Upgrade
Total Liabilities & Equity
3,6883,7193,2512,3692,0731,735
Upgrade
Total Debt
493.1495.7428.4262.9440.4412.3
Upgrade
Net Cash (Debt)
450.4580.4603.2726.4270.9388.7
Upgrade
Net Cash Growth
-43.69%-3.78%-16.96%168.14%-30.31%122.11%
Upgrade
Net Cash Per Share
4.355.605.977.342.773.97
Upgrade
Filing Date Shares Outstanding
98.9799.799.5196.5995.2493.94
Upgrade
Total Common Shares Outstanding
9999.498.796.594.993.5
Upgrade
Working Capital
1,1151,217952.2915.8727829.7
Upgrade
Book Value Per Share
25.6126.0522.6117.7014.4812.04
Upgrade
Tangible Book Value
2,4992,5482,1911,6651,3741,126
Upgrade
Tangible Book Value Per Share
25.2525.6322.2017.2614.4812.04
Upgrade
Machinery
-153.2115.78775.656.8
Upgrade
Leasehold Improvements
-35.938.137.934.929.5
Upgrade
Updated May 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q